Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 6, 2019 - Issue
Submit an article Journal homepage
89
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Nicholas Fidelman1 Department of Radiology and Biomedical ImagingCorrespondence[email protected]
,
Curt Johanson1 Department of Radiology and Biomedical Imaging
,
Maureen P Kohi1 Department of Radiology and Biomedical Imaging
,
K Pallav Kolli1 Department of Radiology and Biomedical Imaging
,
Ryan M Kohlbrenner1 Department of Radiology and Biomedical Imaging
,
Evan D Lehrman1 Department of Radiology and Biomedical Imaging
,
Andrew G Taylor1 Department of Radiology and Biomedical Imaging
,
R Kate Kelley2 Department of Medicine – Division of Gastrointestinal Oncology
,
Francis Y Yao3 Department of Medicine – Division of Hepatology
,
John P Roberts4 Department of Surgery – Division of Transplant Surgery, University of California San Francisco, San Francisco, CA, USA
&
Robert K Kerlan1 Department of Radiology and Biomedical Imaging
 show all
Pages 93-103 | Published online: 17 Jun 2019

References

  • Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739. doi:10.1016/S0140-6736(02)08649-X12049862
  • Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–1171. doi:10.1053/jhep.2002.3315611981766
  • Rubinstein MM, Kaubisch A, Kinkhabwala M, Reinus J, Liu Q, Chuy JW. Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation. J Gastrointest Oncol. 2017;8(6):1051–1055. doi:10.21037/jgo.2017.08.1129299366
  • Yao FY, Kerlan RK, Hirose R, et al. Excellent outcome following downstaging of hepatocellular carcinoma prior to liver. transplantation: an intention-to-treat analysis. Hepatology. 2008;48:819–827. doi:10.1002/hep.2241218688876
  • Yao FY, Mehta N, Flemming J, et al. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015;61(6):1968–1977. doi:10.1002/hep.2775225689978
  • Yao FY, Fidelman N. Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: where do we stand with tumor downstaging? Hepatology. 2016;63(3):1014–1025. doi:10.1002/hep.2813926560491
  • Garwood E, Fidelman N, Hoch SE, Kerlan RK. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and hepatic dysfunction. Liver Transpl. 2013;19:164–173. doi:10.1002/lt.2355223008091
  • Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33(1):41–52. doi:10.1007/s00270-009-9711-719908093
  • Sacco R, Bargellini I, Bertini M, et al. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2011;22:1545–1552. doi:10.1016/j.jvir.2011.07.00221849247
  • Golfieri R, Giampalma E, Renzulli M, et al. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolization for hepatocellular carcinoma. Br J Cancer. 2014;111:255–264. doi:10.1038/bjc.2014.19924937669
  • Chen P, Yuan P, Chen B, Sun J, Shen H, Qian Y. Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2017;41:75–85. doi:10.1016/j.clinre.2016.05.01327350573
  • Poon RT, Tso WK, Pang RW, et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol. 2007;5(9):1100–1108. doi:10.1016/j.cgh.2007.04.02117627902
  • Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46(3):474–481. doi:10.1016/j.jhep.2006.10.02017239480
  • Gomes AS, Monteleone PA, Sayre JW, et al. Comparison of triple-drug transcatheter arterial chemoembolization (TACE) with single-drug TACE using doxorubicin-eluting beads: long-term survival in 313 patients. AJR Am J Roentgenol. 2017;209(4):722–732. doi:10.2214/AJR.17.1821928705059
  • Hansmann J, Evers MJ, Bui JT, et al. Albumin-bilirubin and platelet-albumin-bilirubin grades accurately predict overall survival in high-risk patients undergoing conventional transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28:1224–1231. doi:10.1016/j.jvir.2017.05.02028688815
  • Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013;266:376–382. doi:10.1148/radiol.1212169823362092
  • Kitai S, Kudo M, Nishida N, et al. Survival benefit of locoregional treatment for hepatocellular carcinoma with advanced liver cirrhosis. Liver Cancer. 2016;5:175–189. doi:10.1159/00036776527493893
  • Hiraoka A, Kumada T, Michitaka K, et al. Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study. Hepatol Res. 2016;46(6):521–528. doi:10.1111/hepr.1258326331402
  • Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol. 2007;18:1517–1526. doi:10.1016/j.jvir.2007.07.03518057286

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.